NTRK3 and cancer: Cancer cell populations with the properties of CSCs play a pivotal role in resistance to conventional chemotherapy [1, 5, 6], causing us to also focus on the possible effect of TrkC-mediated inhibition of DJ-1 degradation in chemoresistance.